How do you define growth-driven investment strategies fostering transformative startups and technologies in major APAC markets?
Asia is hitting a sweet spot for companies and investors alike. However, the opportunities for growth within the startup ecosystem also mean that there cannot be a one-size-fits-all investment strategy. Investors must be able to tailor their strategies across specific startups, technologies and even across countries. For example, in Southeast Asia, most ecosystems are still in the early development phase, but countries such as Singapore, Malaysia and Indonesia have already entered the next phase, given their size and rapid development. Singapore, in particular, has become a true leader in the region due to its supportive government policies and dedicated programmes contributing to the success of its startup ecosystem.
Asia holds major growth share within disruptive fields such as additive manufacturing, sustainable nutrition and health-tech solutions. Every investment is a new opportunity for collaboration and breakthroughs. Evonik Venture Capital has already executed a total of eight direct and fund investments in Asia since 2018.
How does Evonik evaluate market dynamics and operational growth in Asian Biomedical R&D and early-stage companies for investment allocations?
This story is from the BioSpectrum Asia Jan 2022 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum Asia Jan 2022 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Sartorius opens new CoE for bioanalytics in US
Germany-headquartered life science group Sartorius has opened its new Center of Excellence (CoE) for bioanalytics in Ann Arbor, Michigan, US two years after breaking ground in the Tech Loop at Research Park.
Singapore-Japan team finds common virus that triggers growth of nasopharyngeal cancer
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how the Epstein-Barr virus (EBV) alters specific genes, making nasopharyngeal cancer tumours (NPC) grow faster.
Prof. Liu Xiaogang wins prestigious Royal Society of Chemistry Prize
Professor Liu Xiaogang from the Department of Chemistry, National University of Singapore (NUS) has been named winner of the Royal Society of Chemistry’s Centenary Prize in recognition of brilliance in research and innovation.
New blood test by Australian scientists tracks brain recovery after concussion
A blood test can accurately detect the ongoing effects of sport-related concussion and help determine when it’s safe to return to the field, Australia's Monash University-led research has found.
Australian Digital Health Agency appoints Dr Amandeep Hansra as new Chief Clinical Adviser (Medicine)
The Australian Digital Health Agency, the Australian Government’s statutory agency responsible for My Health Record, Australia's digital prescriptions and health referral system, and other e-health programmes under the national digital health strategy, has announced the appointment of Dr Amandeep Hansra as its new Chief Clinical Adviser (Medicine).
Macro Callouts for Healthcare Investing in Indial
India will have 1.2 billion people in the middleincome segment with over 42 per cent of the population in urban cities, by 2030. India’s healthcare and lifesciences market is estimated to reach 285 billion by 2028 implying a growth that is twice our GDP growth. These developments will lead to an estimated 30-35 billion in private capital investment getting allocated to the sector over the next 5 years.
Oxford University designs computer simulations to guide future vaccine trials
University of Oxford scientists are launching new computer simulations that will model how we can strengthen the world’s response to some of the viruses most likely to cause the next pandemic.
WHO and Italian National Institute of Health sign MoU to improve care for healthy ageing
The World Health Organization (WHO) and the Dementia Observatory (Osservatorio Demenze) have signed a threeyear Memorandum of Understanding (MoU) to formalise a close collaboration and exchange aimed at improving care for healthy ageing
Noul participates in malaria project initiated by US CDC
On-device AI healthcare startup in South Korea, Noul has announced that it will jointly participate in a malaria diagnosis project initiated by US Centers for Disease Control and Prevention (CDC) with the Kenya Medical Research Institute (KEMRI).
EnGeneIC, Singapore Institute of Advanced Medicine forge partnership to revolutionise cancer treatment in Asia
EnGeneIC, an Australiabased clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nano cell for cancer therapy, has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings (SAM) and Singapore Medical Incorporation (SMI).
